Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bcma car-nk 92 cells (1 trial)
robo1 car-nk cell (2 trials)
robo1 car-nk/t cells (1 trial)
human fecal microbiota (Reybota) (1 trial)
Multiple Myeloma (Phase 2)
Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Trials (5 total)
Trial APIs (4 total)